[The role of infection in the pathogenesis of atherosclerosis]

Maciej Banach1, Leszek Markuszewski, Janusz Zasłonka

  • 1Klinika Kardiochirurgii oraz Oddział Kliniczny Kardiologii Interwencyjnej i Kardiodiabetologii I Katedry Kardiologii i Kardiochirurgii Uniwersytetu Medycznego w Lodzi. maciej.banach@kardiolog.pl

Insights

Infections like Chlamydia pneumoniae and Cytomegalovirus may initiate atherosclerosis. Optimizing current anti-inflammatory therapies is crucial for preventing artery diseases until vaccines are available.

Area of Science:

  • Microbiology
  • Cardiovascular Science
  • Immunology

Context:

  • Atherosclerosis is a chronic inflammatory disease of arteries.
  • Infectious agents are increasingly implicated in cardiovascular disease pathogenesis.
  • Chlamydia pneumoniae and Cytomegalovirus are key suspected pathogens in atherogenesis.

Purpose:

  • To review the role of specific infections in atherosclerosis initiation.
  • To highlight the importance of Chlamydia pneumoniae and Cytomegalovirus in atheromatosis.
  • To emphasize optimizing existing anti-inflammatory therapies for vascular health.

Summary:

  • Experimental and human studies suggest infections initiate atherosclerosis.
  • Chlamydia pneumoniae and Cytomegalovirus are strongly suspected of stimulating atheromatosis.
  • Current evidence supports a role for microbial triggers in arterial plaque formation.

Impact:

  • Informs strategies for preventing infectious triggers of atherosclerosis.
  • Underscores the need for enhanced vascular anti-inflammatory treatments.
  • Guides future research into pathogen-specific interventions for artery disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
350
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
996
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
743
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
602
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K